MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Effects of neural stem cell transplantation on the differentiation of dopaminergic neurons in the substantia nigra and changes to rotational behavior of Parkinson’s disease rats

    J.J. Xiao, X.P. Wang (Shanghai, China)

    Objective: To explore the effects of neural stem cells transplantation on the differentiation of substantia nigra dopaminergic neurons and on the rotational behavior in a…
  • 2018 International Congress

    Decreased amyloid-beta in patients with Idiopathic Parkinson’s Disease and white matter hyperintensities

    I. Markaki, S. Klironomos, P. Svenningsson (Stockholm, Sweden)

    Objective: The aim of this study is to investigate the clinical and biochemical profile of patients with PD with and without WMH. Background: Parkinson’s disease…
  • 2018 International Congress

    A patient with myotonic dystrophy type 1 and parkinsonism

    J. Choi, J. Lee, H. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: We report the first case of myotonic dystrophy (DM) type 1 with DMPK mutations presenting with parkinsonian syndrome. Background: DM type 1 is a…
  • 2018 International Congress

    Suicide attempts, suicidal and death ideation in Parkinson’s disease

    MM. Dumitru, A. Papari (Iasi, Romania)

    Objective: The objective of this study was to assess the correlates of suicidal and death ideation and suicide attempts in patients with parkinson’s disease. Background:…
  • 2018 International Congress

    The International Parkinson and Movement Disorder Society Non-Motor Scale (MDS-NMS) for Parkinson’s Disease: Preliminary results from an international validation

    K. Ray Chaudhuri, D. Weintraub, A. Rizos, A. Schrag, P. Martinez-Martin (London, United Kingdom)

    Objective: To provide an update on the ongoing international validation programme of an expanded, refined and improved scale for the assessment of non-motor symptoms (NMS)…
  • 2018 International Congress

    Feasibility and Efficacy of Brainstem Modulation Therapy for the Management of Parkinson’s Disease

    K. Ade, A. Podlewska, T. Pellet-Higgins, S. Banducci, M. Bodani, M. Sakel, D. Wilkinson (Raleigh, NC, USA)

    Objective: To evaluate the feasibility and potential efficacy of a software-controlled, solid-state caloric vestibular stimulation (CVS)-mediated brainstem modulation device for the treatment of non-motor and…
  • 2018 International Congress

    Training in parkinsonism among health providers in Cameroon

    M. Kurtis, M. Monje, C. Delgado-Suarez, I. Garcia-Morales, P. Gomez-Iglesias, M. Molina, D. Garcia-Azorin (Madrid, Spain)

    Objective: To describe the knowledge of parkinsonian movement disorders in a sample of Cameroonian health providers and the impact of a basic training course. Background:…
  • 2018 International Congress

    Correlation between cerebral perfusion and striatal dopamine transporter activity by dual SPECT study in Parkinsonian syndromes

    Y. Nakano, S. Hirano, K. Kojima, H. Li, A. Ishikawa, T. Sakurai, H. Tai, H. Mukai, T. Horikoshi, T. Uno, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to investigate the correlations between brain perfusion and striatal dopamine transporter (DAT) activity in parkinsonian syndromes and to characterize the difference in…
  • 2018 International Congress

    Variation in the L-dopa motor response in pathologically confirmed Parkinson’s disease

    V. Pitz, N. Malek, K. Grosset, D. Grosset (Glasgow, United Kingdom)

    Objective: To examine the L-dopa-response (improvement in motor symptoms) in published cases of pathologically confirmed Parkinson’s disease (PD). Background: L-dopa responsiveness supports the diagnosis of…
  • 2018 International Congress

    Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson’s disease patients: Bulgarian experience

    E. Chorbadzhieva (Sofia, Bulgaria)

    Objective: To evaluate the efficacy of levodopa/carbidopa intestinal gel (LCIG) on motor fluctuations, dyskinesia, parkinson symptoms and quality of life in patients with late Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 247
  • 248
  • 249
  • 250
  • 251
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley